Researcher in
Cell stress and resultant cell death can lead to loss of tissue and organ function and plays a major part in many diseases. Oxidative stress (OS) is implicated in conditions such as atherosclerosis, cancer, macular degeneration and various neurodegenerative disorders such as Parkinson’s, Huntington’s and Alzheimer’s. OS occurs when there is a malfunction in the cell’s ability to neutralise free radicals; this results in an insufficient supply of antioxidants and may result in a net increase in the amount of free radicals present in the local cellular environment. This can lead to irreversible cell damage, which may result in mutagenic effects and tissue injury. We are using lentiviral vectors to transduce mesenchymal stem cells to promote survival under both oxidative and hypoxic conditions.
2005-present
PhD Student
REMEDI (Prof. Tim O’Brien)
Gene Therapy using Lentiviral Vectors
Summer 2005
Research Assistant
REMEDI (Prof. Tim O’Brien)
Gene Therapy for Macular Degeneration using Adenoviral Vectors
Summer 2004
Undergraduate -
Professional Experience Programme (PEP)
European Molecular Biology Lab (EMBL), Heidelberg, Germany
Cell Biology and Biophysics
2001-2005
Undergraduate -
BSc in Biotechnology
National University of Ireland, Galway
BSc project: A Gene Therapy Approach to Macular Degeneration
Poster Presentaions:
Viral Vector Mediated Delivery of Antioxidant and Anti-Apoptotic Proteins. Irish Society of Gene and Cell Therapy, NUI Cork, Ireland.
May 2008
Viral vector Mediated Protection from Oxidative Stress using Antioxidant Enzymes. Irish Society of Gene and Cell Therapy, NUI Galway, Ireland.
May 2007
Anti-Oxidant Gene Delivery to Retinal Epithelial Cells: A Gene Therapy Approach for Macular Degeneration. American Society of Gene Therapy 9th Annual Meeting, Baltimore, MD, USA.
May 2006



